Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial

NCT06319378 is registered in ClinicalTrials.gov with Section for Affective Disorders; Northern Stockholm Psychiatry as lead sponsor.

NCT NCT06319378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06319378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial
Lead sponsor
Section for Affective Disorders; Northern Stockholm Psychiatry
Phase
Phase 2
Overall status
Recruiting
Start date
April 19, 2024
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

mdd